Clinical Trial: MK0859 Dose-Ranging Study (0859-003)

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of MK-0859 in Patients With Primary Hypercholesterolemia or Mixed Hyper

Brief Summary: To assess the cholesterol changing effects of MK0859 in patients with primary hypercholesterolemia or mixed dyslipidemia.

Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.

Current Primary Outcome: To assess the cholesterol changing effects of MK0859

Original Primary Outcome:

Current Secondary Outcome: Acceptable safety profile

Original Secondary Outcome:

Information By: Merck Sharp & Dohme Corp.

Dates:
Date Received: May 11, 2006
Date Started: June 2006
Date Completion:
Last Updated: February 27, 2015
Last Verified: February 2015